Inventor · disambiguated record
Andrew J. Tebben
Also filed as: TEBBEN ANDREW · TEBBEN ANDREW J
21 granted patents·1 pending application·420 citations·filing 1998–2017
95Inventor score
Files withBRISTOL MYERS SQUIBB CO11MERCK & CO INC5LIU CHUNJIAN2BORZILLERI ROBERT M1DE LUCCA GEORGE V1
Top patents by PatentIndex Score
22 records- 0194US8362065B2Carbazole carboxamide compounds useful as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2011·Granted Jan 29, 2013·32 cites·20 claims
- 0294US6841367B2Human receptor tyrosine kinase, KDRMERCK & CO INC·Filed 2002·Granted Jan 11, 2005·36 cites·6 claims
- 0394US6359115B1Human receptor tyrosine kinase, KDRMERCK & CO INC·Filed 2000·Granted Mar 19, 2002·55 cites·6 claims
- 0493US8084620B2Carbazole carboxamide compounds useful as kinase inhibitorsLIU QINGJIE·Filed 2009·Granted Dec 27, 2011·60 cites·22 claims
- 0593US6841382B2Human receptor tyrosine kinase, KDRMERCK & CO INC·Filed 2001·Granted Jan 11, 2005·31 cites·6 claims
- 0693US6204011B1Human receptor tyrosine kinase, KDRMERCK & CO INC·Filed 1998·Granted Mar 20, 2001·84 cites·26 claims
- 0789US8586751B2Nicotinamide compounds useful as kinase modulatorsDE LUCCA GEORGE V·Filed 2010·Granted Nov 19, 2013·32 cites·10 claims
- 0889US6265403B1Angiogenesis inhibitorsMERCK & CO INC·Filed 2000·Granted Jul 24, 2001·40 cites·4 claims
- 0986US8188272B2Fused heterocyclic compounds useful as kinase modulatorsLIU CHUNJIAN·Filed 2008·Granted May 29, 2012·11 cites·11 claims
- 1083US9708316B2TGFβR antagonistsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Jul 18, 2017·5 cites·13 claims
- 1183US9688694B2Macrocyclic benzodiazepine dimers, conjugates thereof, preparation and usesBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Jun 27, 2017·3 cites·17 claims
- 1282US8476430B2Fused heterocyclic compounds useful as kinase modulatorsLIU CHUNJIAN·Filed 2009·Granted Jul 2, 2013·6 cites·11 claims
- 1382US6525044B2Succinoylamino carbocycles and heterocycles as inhibitors of a-β protein productionBRISTOL MYERS SQUIBB CO·Filed 2001·Granted Feb 25, 2003·14 cites·18 claims
- 1480US9802915B2Indole carboxamide compoundsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Oct 31, 2017·1 cites·15 claims
- 1576US7557137B2Gamma-lactams as beta-secretase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Jul 7, 2009·9 cites·7 claims
- 1668US10023534B2Carbazole and tetrahydrocarbazole compounds useful as inhibitors of BTKBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Jul 17, 2018·1 cites·13 claims
- 1763US9902740B2Macrocyclic benzodiazepine dimers, conjugates thereof, preparation and usesBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Feb 27, 2018·0 cites·1 claims
- 1842US10308652B2Tricyclic heterocyclic compounds useful as inhibitors of TNFBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Jun 4, 2019·0 cites·3 claims
- 1940US9346795B2Substituted sulfonamides useful as antiapoptotic Bcl inhibitorsBORZILLERI ROBERT M·Filed 2012·Granted May 24, 2016·0 cites·12 claims
- 2037US2019292179A1TGF Beta RECEPTOR ANTAGONISTSBRISTOL MYERS SQUIBB CO·Filed 2017·Application pending·0 cites
- 2134US10189840B2Substituted tricyclic heterocyclic compoundsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Jan 29, 2019·0 cites·9 claims
- 2229US9040526B2Benzylpyrrolidinone derivatives as modulators of chemokine receptor activityMANGION IAN K·Filed 2011·Granted May 26, 2015·0 cites·12 claims
Join the waitlist — get patent alerts
Get an alert when Andrew J. Tebben files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →